Our findings that EGFR expression influenced the response of HCC cells to dasatinib further strengthened the notion that a unique cross-talk mechanism might exist between Src family and EGFR family tyrosine kinases in hepatocarcinogenesis. The gene discussed is EGFR; the disease is hepatocellular carcinoma.